U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285278) titled 'Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above' on Dec. 03.
Brief Summary: The primary objective of this study is to evaluate the immunogenicity and safety of 2 injections (approximately 2 months apart) of ABO1108 in adults aged 40 years or above.
Study Start Date: Nov. 15
Study Type: INTERVENTIONAL
Condition:
Varicella-zoster Virus
Intervention:
BIOLOGICAL: ABO1108
Formulation for injection
DRUG: Placebo
0.9% sodium chloride (normal saline) injection
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Published by HT Digital Content S...